Glenmark Pharmaceuticals announced that Hocine Sidi, Director of the company has resigned from the Board with effect from November 25, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,242 INR | +0.52% | +1.49% | +45.57% |
Jun. 12 | India Equities Close Higher Ahead of US Inflation Data | MT |
Jun. 12 | Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.57% | 4.21B | |
+17.42% | 43.78B | |
+17.04% | 21.56B | |
+21.10% | 15.64B | |
+24.65% | 15.25B | |
+55.40% | 13.02B | |
-0.05% | 6.79B | |
-16.34% | 6.36B | |
+19.77% | 5.81B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Announces Resignation of Hocine Sidi as Director